336 related articles for article (PubMed ID: 28624451)
1. Rapamycin protects against paraquat-induced pulmonary fibrosis: Activation of Nrf2 signaling pathway.
Xu Y; Tai W; Qu X; Wu W; Li Z; Deng S; Vongphouttha C; Dong Z
Biochem Biophys Res Commun; 2017 Aug; 490(2):535-540. PubMed ID: 28624451
[TBL] [Abstract][Full Text] [Related]
2. Effects of rapamycin against paraquat-induced pulmonary fibrosis in mice.
Shao X; Li M; Luo C; Wang YY; Lu YY; Feng S; Li H; Lang XB; Wang YC; Lin C; Shen XJ; Zhou Q; Jiang H; Chen JH
J Zhejiang Univ Sci B; 2015 Jan; 16(1):52-61. PubMed ID: 25559956
[TBL] [Abstract][Full Text] [Related]
3. MAPK pathway mediates epithelial-mesenchymal transition induced by paraquat in alveolar epithelial cells.
Huang M; Wang YP; Zhu LQ; Cai Q; Li HH; Yang HF
Environ Toxicol; 2016 Nov; 31(11):1407-1414. PubMed ID: 25873302
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α regulates EMT via the Snail and β-catenin pathways in paraquat poisoning-induced early pulmonary fibrosis.
Zhu Y; Tan J; Xie H; Wang J; Meng X; Wang R
J Cell Mol Med; 2016 Apr; 20(4):688-97. PubMed ID: 26781174
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin attenuates paraquat poisoning-induced epithelial-mesenchymal transition via downregulating hypoxia-inducible factor-1 alpha.
Du J; Zhu Y; Meng X; Xie H; Wang J; Zhou Z; Wang R
Life Sci; 2018 Nov; 213():126-133. PubMed ID: 30336147
[TBL] [Abstract][Full Text] [Related]
6. Involvement of epithelial-to-mesenchymal transition and associated transforming growth factor-β/Smad signaling in paraquat-induced pulmonary fibrosis.
Han YY; Shen P; Chang WX
Mol Med Rep; 2015 Dec; 12(6):7979-84. PubMed ID: 26499763
[TBL] [Abstract][Full Text] [Related]
7. Paraquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells.
Yamada A; Aki T; Unuma K; Funakoshi T; Uemura K
PLoS One; 2015; 10(3):e0120192. PubMed ID: 25799450
[TBL] [Abstract][Full Text] [Related]
8. Paraquat induce pulmonary epithelial-mesenchymal transition through transforming growth factor-β1-dependent mechanism.
Xie L; Zhou D; Xiong J; You J; Zeng Y; Peng L
Exp Toxicol Pathol; 2016 Jan; 68(1):69-76. PubMed ID: 26603905
[TBL] [Abstract][Full Text] [Related]
9. Radix puerariae extracts ameliorate paraquat-induced pulmonary fibrosis by attenuating follistatin-like 1 and nuclear factor erythroid 2p45-related factor-2 signalling pathways through downregulation of miRNA-21 expression.
Liu MW; Liu R; Wu HY; Li YY; Su MX; Dong MN; Zhang W; Qian CY
BMC Complement Altern Med; 2016 Jan; 16():11. PubMed ID: 26758514
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin attenuates the paraquat-induced pulmonary fibrosis through activating Nrf2 pathway.
Tai W; Deng S; Wu W; Li Z; Lei W; Wang Y; Vongphouttha C; Zhang T; Dong Z
J Cell Physiol; 2020 Feb; 235(2):1759-1768. PubMed ID: 31301076
[TBL] [Abstract][Full Text] [Related]
11. [Role of MAPK signaling pathway in epithelial-mesenchymal transition of type II alveolar epithelial cells induced by Paraquat].
Zhu CD; Guo MZ; Cai Q; Li YY; Wu KX; Huang M
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Aug; 36(8):561-567. PubMed ID: 30317802
[No Abstract] [Full Text] [Related]
12. Rapamycin protects against paraquat-induced pulmonary epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
Vongphouttha C; Zhu J; Deng S; Tai W; Wu W; Li Z; Lei W; Wang Y; Dong Z; Zhang T
Exp Ther Med; 2018 Mar; 15(3):3045-3051. PubMed ID: 29599839
[TBL] [Abstract][Full Text] [Related]
13. A positive feedback loop promotes HIF-1α stability through miR-210-mediated suppression of RUNX3 in paraquat-induced EMT.
Zhu Y; Wang J; Meng X; Xie H; Tan J; Guo X; Han P; Wang R
J Cell Mol Med; 2017 Dec; 21(12):3529-3539. PubMed ID: 28699703
[TBL] [Abstract][Full Text] [Related]
14. Paraquat induces pulmonary fibrosis through Wnt/β-catenin signaling pathway and myofibroblast differentiation.
Sun Z; Yang Z; Wang M; Huang C; Ren Y; Zhang W; Gao F; Cao L; Li L; Nie S
Toxicol Lett; 2020 Oct; 333():170-183. PubMed ID: 32795487
[TBL] [Abstract][Full Text] [Related]
15. Expression and significance of HIF-1α in pulmonary fibrosis induced by paraquat.
Xie H; Tan JT; Wang RL; Meng XX; Tang X; Gao S
Exp Biol Med (Maywood); 2013 Sep; 238(9):1062-8. PubMed ID: 24048193
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic effect of atorvastatin on paraquat-induced pulmonary fibrosis: role of PPARγ receptors.
Malekinejad H; Mehrabi M; Khoramjouy M; Rezaei-Golmisheh A
Eur J Pharmacol; 2013 Nov; 720(1-3):294-302. PubMed ID: 24161914
[TBL] [Abstract][Full Text] [Related]
17. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
18. Losartan attenuates paraquat-induced pulmonary fibrosis in rats.
Guo F; Sun YB; Su L; Li S; Liu ZF; Li J; Hu XT; Li J
Hum Exp Toxicol; 2015 May; 34(5):497-505. PubMed ID: 25233898
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum stress promotes epithelial‑mesenchymal transition via the PERK signaling pathway in paraquat‑induced pulmonary fibrosis.
Meng X; Liu K; Xie H; Zhu Y; Jin W; Lu J; Wang R
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036384
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin attenuates lung fibroblasts activation and pulmonary fibrosis induced by paraquat.
Yao R; Cao Y; He YR; Lau WB; Zeng Z; Liang ZA
PLoS One; 2015; 10(5):e0125169. PubMed ID: 25945502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
